Whaley Bridge, High Peak, United Kingdom

Michael John Sherratt

This inventor holds 1 USPTO granted patent and 3 published patent applications and 3 EPO patents. Top assignee: The Boots Company Plc. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael John Sherratt: Innovator in Tetrapeptide Technology

Introduction

Michael John Sherratt is a notable inventor based in Whaley Bridge, High Peak, GB. He has made significant contributions to the field of biochemistry, particularly through his work on tetrapeptides. His innovative approach has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

Michael holds a patent titled "TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES." This patent highlights his research and development in the area of peptide technology, which has potential applications in various industries, including pharmaceuticals and cosmetics. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.

Career Highlights

Michael is currently employed at The Boots Company Plc, where he applies his skills and knowledge to further the company's research initiatives. His role involves collaborating with other experts in the field to explore new possibilities in product development and innovation.

Collaborations

Michael has worked alongside talented colleagues, including Yegor Doush and Matiss Ozols. Their combined efforts contribute to a dynamic research environment that fosters creativity and innovation.

Conclusion

Michael John Sherratt is a dedicated inventor whose work in tetrapeptide technology exemplifies the spirit of innovation. His contributions to the field are significant, and his ongoing research promises to yield exciting advancements in the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…